Senior Biotechnologist I

Sanofi; Singapore; On-site; SGD 90,000 - 130,000; Full time

Job summary

Sanofi in Singapore's Tuas campus seeks a Senior Biotechnologist, Manufacturing, to join the pioneering shift team and lead commissioning, qualification, and GMP operations for a new modular facility slated for early 2026.

The role covers tech transfer, training, deviation investigations and continuous improvement across upstream/downstream processes, with a 12-hour rotating shift including weekends when fully operational. The position involves digital systems like MES, ERP and QMS.

Qualifications

• Bachelor’s degree in Engineering or Life Science with >3 years in biopharmaceutical manufacturing.
• Diploma with >5 years in biopharma manufacturing is acceptable.
• Experience with GMP operations and digital systems is preferred.

Responsibilities

• Perform and complete commissioning and qualification activities for equipment and digital systems.
• Execute routine GMP manufacturing activities in line with Process, Quality and Safety standards.
• Conduct training for workflows and procedures; ensure housekeeping and regulatory readiness.
• Support continuous improvement, deviations investigations, and QMS responses.

Skills

Good communication

Team player

Analytical skills

Proactive

Education

Bachelor’s degree (Engineering / Life Science / Biology / Chemistry)

Diploma (Engineering / Life Science / Biology / Chemistry)

Tools

MES

ERP

QMS

AGVs

Job description

Sanofi Manufacturing and Supply (M&S) Organization is preparing its future through an ambitious program named Modulus. The facility is at the cornerstone of Sanofi strategy as it aims at creating a new manufacturing concept consisting of a new generation of evolutive multi-product facilities, modular, adaptable, and agile, leveraging new disruptive technologies, to better address vaccine business challenges as well as Specialty Care Biologics products. One of these two Modulus Facilities is constructed in Singapore at a new Greenfield site, with a design identical to the one in Neuville (France). The facilities will also have highly digitalized and automated capabilities which is a key enabler for operations using technologies such as autonomous guided vehicles, cobots and cloud systems.

This role will have the title of Senior Biotechnologist, Manufacturing and will report to the Manager, Manufacturing. The successful candidate will be part of the pioneer batch of the manufacturing operations shift team who will directly participate in the Engineering and Product Validation Runs in the state-of-the-art facility planned for early 2026.

The candidate will have a routine operational role consisting of the following:

• Perform and complete ongoing commissioning and qualification activities of equipment, digital and automation related systems.

• Execute routine GMP manufacturing activities in the manufacturing operations team in accordance with Process, Quality and Safety standards.

• Conduct Training activities to the team for specific assigned workflows and procedures.

• Ensure general housekeeping of all manufacturing areas.

• Support ongoing regulatory and audit readiness and preparation.

• User of key digital and automation applications and software related to manufacturing systems such as ERP, MES, PCS, etc.

• Support continuous improvement and optimization projects.

• Investigate deviations and exceptions including process abnormalities and critical alarms on QMS. Take immediate actions to minimize product and schedule impact.
  

Sanofi Tuas Singapore is hiring for Senior Biotechnologist, Manufacturing for the following teams:

• Upstream Manufacturing Process

• Downstream Manufacturing Process

• Central Manufacturing Services (Media & Buffer, Logistics)

Performance Standards: Duties & Responsibilities

Key Areas

Action Areas, Deliverables and Outcomes

Weightage

(Total 100%)

Commissioning and Qualification Activities, Operational Readiness

• Perform and execute commissioning activities for manufacturing equipment and systems.

• Support the documentation readiness for procedures, risk assessment and other training documents for the manufacturing equipment and systems.

20%

Tech Transfer

• Participate and complete all related trainings to perform the tech transfer runs.

30%

cGMP Manufacturing Operations

• Perform and participate in the Engineering Runs and other Product Validation Runs

50%

Pre-requisites

Knowledge, Skills & Competencies / Language

• Good communication skills and a team player

• Proven ability to work as part of an integrated, networked team, and collaborate across functional, organizational, and location boundaries and be people-first values driven

• Excellent analytical, consultative, and diagnostic skills with ability to make sound, data-based business decisions.

• Engaging, dynamic

• Adaptable, relationship focused.

• Self-organized.

• Proactive, Result-oriented.

• Start-up and /or commissioning, qualification of a biopharmaceutical facility would be an advantage.

• Familiarity and prior working experience with Single Use Systems would be preferred.

• Good knowledge and experience in related GMP operations based on the manufacturing team.

• Good knowledge and interest to work with fully digital and automated systems will be preferred. Systems including but not limited to Manufacturing Execution Systems (MES), Enterprise Resource Systems (ERPs), Autonomous Guided Vehicles (AGVs), robotics, conveyor systems, Quality Management Systems (QMS), etc.

Qualifications / Requirements

• Bachelor’s degree (in Engineering / Life Science / Biology / Chemistry) with >3 Years of experience in Biopharmaceutical Manufacturing (biologics or vaccines).

• Diploma (in Engineering / Life Science / Biology / Chemistry) with >5 Years of experience in Biopharmaceutical Manufacturing (biologics or vaccines).

Any other requirements of the job

• Senior Biotechnologist will be working in a twelve-hour rotating shift pattern consisting of day and night shifts which will include weekend workdays when the facility is fully operational expected to be in mid of 2026.